🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Cette stratégie s’inscrit parfaitement dans notre vision de développement d’ExCellThera en sol québécois. -- This strategy is perfectly in line with our vision of developing ExCellThera on Quebec soil.

We are excited to share that four UM171 presentations, including an oral session on new data from Phase 2 studies of UM171 cell therapy, will be featured at #ASH2023. excellthera.com/news/excellthe… #UM171

ExCellThera will present at the #BiotechShowcase on Jan 8 at 4:45 PT and hold investor meetings during the JP Morgan #Healthcare Conference, Jan 8-11, in San Francisco. excellthera.com/news/excellthe… #UM171

See highlights of data recently presented by Filippo Milano at #ASH2023 using our #UM171 Cell Therapy in patients with high risk blood cancers. youtube.com/watch?v=l1sYcv… VJHemOnc

ExCellThera announces #research published in Blood that expands on #UM171 mechanism of action and highlights its potential to create improved blood stem cell therapies, including our UM171 Cell Therapy. excellthera.com/news/excellthe… #celltherapy

ExCellThera's Chief Scientific Officer, Guy Sauvageau, will present on advances of blood stem cell expansion using #UM171,  leading to impressive clinical results at #EBMT24 in Glasgow, Scotland. excellthera.com/news/excellthe…